• One-third of Patients Denied New Hepatitis C Drugs

    13 days ago - By Medscape

    Despite an overall greater availability of direct-acting antivirals, absolute denials by insurers increased during 2016-2017 and remained high regardless of insurance type.
    Medscape Medical News
    Read more ...